|
Wearable-technology-maker Kopin Corp. has acquired a majority stake e-MDT America, an expert in low-power analog/digital circuit designs, Kopin announced Monday.
more
By PBN Staff
|
|
The unique technology of Providence-based Nabsys Inc., a life sciences company focused on technology for analyzing DNA, has garnered industry attention nationally. The company recently closed a $20 million financing round. Dr. Barrett Bready, president, CEO and a Rhode Island-native, discusses his company’s recent success, its unique technology and the future of the state’s biotech industry.
more
By Emily Greenhalgh |
|
When you sell remote boat monitors, your market covers the waterways of the world.
more
By Rhonda Miller |
|
Solar energy to date has largely been focused on buildings – business and residential – and ways in which their inhabitants can reduce carbon footprints via personal responsibility.
more
By Rebecca Keister |
|
Cybersecurity experts are increasingly concerned that the nation’s future leaders are unprepared to deal with the digital threats programmers and cryptographers are wrestling with.
more
By Patrick Anderson |
|
Metryx, a social-venture project hoping to change education via use of a mobile assessment platform, says it is making great strides toward making the application available in a schoolwide format next fall.
more
By Rebecca Keister |
|
Consumers can seemingly buy everything online. From cars to clothing and even local produce – the Internet connects buyers and sellers in a way that has never before been possible.
more
By Emily Greenhalgh |
|
The bottom line of KVH Industries Inc. moved into the black during the first quarter of 2013 after a $1.38 million loss during the first quarter of 2012, the company reported Friday.
more
By PBN Staff
|
|
Hub Network, a multi-platform joint venture between Hasbro Inc. and Discovery Communications, has posted its 16th consecutive month of gains, Hasbro announced Wednesday.
more
By PBN Staff
|
|
Amgen Inc.’s Neulasta and Neupogen and a similar blood-boosting drug from Teva Pharmaceutical Industries Ltd. may help people survive after a nuclear attack, U.S. regulators said.
more
By Anna Edney |